AnalystBook Research · Company Intelligence

AEMETIS, INC

AMTXNasdaq

Built from AEMETIS, INC's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Aemetis posted a $77.0M net loss, free cash flow improved to -$22.7M, and tagged segment revenue was $197.6M.

The read at a glance✓ Audited against SEC data
  • Business mixRenewable fuels and dairy RNGNote
  • RevenueTagged segment revenue was $197.6MNote
  • ProfitabilityNet loss narrowed 12.0%Note
  • CashFree cash flow was -$22.7MWatch
  • Balance sheetDebt fell, but equity worsenedWatch
  • Insiders0 buys / 1 sellWatch
  • AccountingLatest Altman-Z distress; Beneish flagWatch

Business

Aemetis is a renewable natural gas and renewable fuels company with California ethanol, California dairy RNG, and India biodiesel operations.

Where the revenue comes from

Fiscal 2025, as AEMETIS, INC reports it. History and quarterly detail are in the app.

  • California Ethanol$153.2M
  • India Biodiesel$29.7M
  • California Dairy Renewable Natural Gas$14.7M

Leadership changes

From AEMETIS, INC's own filings, the day they're filed.

  • J. Michael Rockett · President · appointmenteff. 2023-08-28

Latest filings

  • 8-K · Company announcement2026-08-06
  • 10-Q · Quarterly report2026-08-06
  • 8-K · Company announcement2026-05-26
  • 10-Q · Quarterly report2026-05-07
  • 8-K · Company announcement2026-05-07
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about AEMETIS, INC, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.